Prosecution Insights
Prosecution Insights
70 pending office actions • 43 clients • 65 examiners • 52 art units • 0 of 70 (0%) have an AI response strategy ready • 71 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 45 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 45 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 4 (6%) |
| §103 only | 39 (56%) |
| §102 only | 8 (11%) |
| §112 only | 9 (13%) |
| Double-patenting only | 3 (4%) |
| Double-patenting + other | 5 (7%) |
| No statute on record | 2 (3%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FUBARA, BLESSING M | 3 | 62.1% | +34.0% |
| BONAPARTE, AMY C | 2 | 79.5% | +23.0% |
| FIEBIG, RUSSELL G | 2 | 62.7% | +25.8% |
| RENNER, BRANDON M | 2 | 81.3% | +21.0% |
| KIRKWOOD, SPENCER HAMMETT | 1 | 50.8% | +12.0% |
| KASSA, TIGABU | 1 | 36.5% | +28.2% |
| ABBOTT-LEWIS, YVONNE RENEE | 1 | 78.3% | +7.9% |
| GEMBEH, SHIRLEY V | 1 | 63.2% | +33.6% |
| FRENCH, CORRELL T | 1 | 46.2% | +33.5% |
| UTAMA, ROBERT J | 1 | 60.4% | +29.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17567400 | Wireless Communication Methods | RENNER, BRANDON M | 87d overdue |
| 16853599 | Electronic Control Device | RENNER, BRANDON M | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18561963 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR INFECTIOUS DISEASE RECOVERY AND USE THEREOF | BOECKELMAN, JACOB A | 50d overdue |
| 18887482 | Method and System for Generating Solution Explanations for Learning Problems | UTAMA, ROBERT J | 15d overdue |
| 17361763 | Personalized Medicine Approach for Treating Cognitive Loss | AKOGYERAM II, NICHOLAS A | 27d |
| 16312346 | Blood Test for Screening Out Amyloid and Alzheimers Disease Presence | CHERNYSHEV, OLGA N | 70d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17567400 | Wireless Communication Methods | RENNER, BRANDON M | 87d overdue |
| 19281151 | METHOD AND APPARATUS TO PROVIDE AN INTEGRATED UNIFIED HEAT SOURCE FOR CHAFING DISHES | KIRKWOOD, SPENCER HAMMETT | 50d overdue |
| 18887482 | Method and System for Generating Solution Explanations for Learning Problems | UTAMA, ROBERT J | 15d overdue |
| 18770850 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE OR DI- N-ACETYL CYSTEINE AMIDE AND DERIVATIVES | BONAPARTE, AMY C | 14d |
| 18678550 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE OR DI- N-ACETYL CYSTEINE AMIDE AND DERIVATIVES | BONAPARTE, AMY C | 14d |
| 19173475 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE, DERIVATIVES AND TABLETS THEREOF | KASSA, TIGABU | 40d |
| 19186888 | TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION | FUBARA, BLESSING M | 53d |
| 18887252 | Method and System for Generating Learning Problems | FRENCH, CORRELL T | 60d |
| Art Unit | Apps |
|---|---|
| 1613 | 3 |
| 1655 | 3 |
| 3715 | 2 |
| 1692 | 2 |
| 1623 | 2 |
| 3775 | 2 |
| 1651 | 2 |
| 1693 | 2 |
| 1621 | 2 |
| 1628 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19281151 | METHOD AND APPARATUS TO PROVIDE AN INTEGRATED UNIFIED HEAT SOURCE FOR CHAFING DISHES | Iph LLC | KIRKWOOD, SPENCER HAMMETT | 3761 | §103 | Final Rejection | 50d overdue | Pending | Jul 25, 2025 |
| 19186888 | TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION | Texas Tech University System | FUBARA, BLESSING M | 1613 | §103 | Non-Final OA | 53d | Pending | Apr 23, 2025 |
| 19173475 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE, DERIVATIVES AND TABLETS THEREOF | Nacuity Pharmaceuticals, Inc. | KASSA, TIGABU | 1619 | §103 | Non-Final OA | 40d | Pending | Apr 08, 2025 |
| 19172058 | AUTOMATED CANINE LINE-UP FOR DETECTION DOG RESEARCH | Texas Tech University System | ABBOTT-LEWIS, YVONNE RENEE | 3644 | §103 | Non-Final OA | — | Pending | Apr 07, 2025 |
| 18910067 | Crenolanib for Treating FLT3 Mutated Proliferative Disorders | Arog Pharmaceuticals, Inc. | GEMBEH, SHIRLEY V | DP | Non-Final OA | — | Pending | Oct 09, 2024 | |
| 18887252 | Method and System for Generating Learning Problems | Mata Edu, Inc. | FRENCH, CORRELL T | 3715 | §103 | Non-Final OA | 60d | Pending | Sep 17, 2024 |
| 18887482 | Method and System for Generating Solution Explanations for Learning Problems | Mata Edu, Inc. | UTAMA, ROBERT J | 3715 | §101 | Final Rejection | 15d overdue | Pending | Sep 17, 2024 |
| 18814725 | Systems and Methods for Angiogenic Treatment in Wound Healing | Venturis Therapeutics, Inc. | MOLOYE, TITILAYO | DP | Non-Final OA | — | Pending | Aug 26, 2024 | |
| 18770850 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE OR DI- N-ACETYL CYSTEINE AMIDE AND DERIVATIVES | Nacuity Pharmaceuticals, Inc. | BONAPARTE, AMY C | 1692 | §102 | Final Rejection | 14d | Pending | Jul 12, 2024 |
| 18770014 | ANCHOR AND INTERBODY FOR INTERBODY FUSION | Evolution Spine, LLC | LITTLE, ANNA VICTORIA | 3773 | §103 | Non-Final OA | — | Pending | Jul 11, 2024 |
| 18719116 | REVERSAL OF SENESCENCE BY ULTRASOUND IRRADIATION | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | CWERN, JONATHAN | 3797 | §103 | Final Rejection | — | Pending | Jun 12, 2024 |
| 18678550 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE OR DI- N-ACETYL CYSTEINE AMIDE AND DERIVATIVES | Nacuity Pharmaceuticals, Inc. | BONAPARTE, AMY C | 1692 | §102 | Final Rejection | 14d | Pending | May 30, 2024 |
| 18659427 | MODIFIED CARBAPENEM ANTIBIOTICS WITH IMPROVED ACTIVITY AGAINST KPC CARBAPENEMASE-PRODUCING ENTEROBACTERALES | Southern Methodist University | CHENG, KAREN | 1623 | §103 | Non-Final OA | — | Pending | May 09, 2024 |
| 18628192 | Bone Reshaping Tool and Method | Texas Scottish Rite Hospital For Children | SIPP, AMY R. | 3775 | §103 | Final Rejection | — | Pending | Apr 05, 2024 |
| 18614071 | Fetal Microchimeric Cells and EVs for Regenerative Medicine in Women's Health | University Of Vermont And State Agricultural College | CLARKE, TRENT R | 1651 | §103 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18693693 | Triple Drug Combination (Metformin, Simvastatin, Digoxin) for Targeted Treatment of Colorectal Cancer | Whispergenics. Inc. | GALSTER, SAMUEL LEONARD | 1693 | DPOther | Final Rejection | 63d | Pending | Mar 20, 2024 |
| 18692976 | Method for Promoting Production of Exopolysaccharide by Bifidobacterium Bacteria | Tohoku University | EPSTEIN, TODD MATTHEW | 1652 | §112 | Non-Final OA | 75d | Pending | Mar 18, 2024 |
| 18688533 | Power Amplifier System in a Package | 3D Glass Solutions, Inc. | LEE, CHEUNG | 2812 | §103 | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18427115 | System and Method for Securing a Document with a Printed Geometric Security Background | Dbp Communications, Inc. | LEWIS, JUSTIN V | 3637 | §103 | Non-Final OA | 30d overdue | Pending | Jan 30, 2024 |
| 18568393 | REMOTELY CONTROLLABLE RESCUE VESSEL | Australian Droid & Robot Pty Ltd. | BURGESS, MARC R | 3615 | §103 | Non-Final OA | 23d | Pending | Dec 08, 2023 |
| 18561963 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR INFECTIOUS DISEASE RECOVERY AND USE THEREOF | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | BOECKELMAN, JACOB A | 1655 | §101 | Final Rejection | 50d overdue | Pending | Nov 17, 2023 |
| 18560456 | APPLICATION OF ALGINATE OLIGOSACCHARIDES | Haitang (Jiangsu) Biotechnology Company, Ltd. | BRANDSEN, BENJAMIN MICHAEL | 1693 | §102 | Non-Final OA | 9d | Pending | Nov 13, 2023 |
| 18506519 | PROX1 PREVENTS MYXOMATOUS VALVE DISEASE BY INHIBITING PDGF-B SIGNALING | Oklahoma Medical Research Foundation | KONOPKA, CATHERINE ANNE | 1635 | §112 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18492092 | COMPOSITIONS AND METHODS FOR THERMAL SKIN TREATMENT WITH METAL NANOPARTICLES | Coronado Aesthetics, LLC | YU, HONG | 1614 | §103 | Final Rejection | 89d overdue | Pending | Oct 23, 2023 |
| 18473958 | MICROPUMP | Lynntech, Inc. | SCHMIDT, EMILY LOUISE | 3783 | §103 | Non-Final OA | 50d overdue | Pending | Sep 25, 2023 |
| 18468020 | Fluorescence Detection of Circulating Cell Free DNA Including Within Extracellular Vesicles in Biospecimens and Liquid Biopsies | Kansas State University Research Foundation | ALABI, OYELEYE A | 1797 | §103 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18468050 | Hook-Spring Plate for Growth Modulation of Immature Rib to Correct Early Onset Scoliosis | Texas Scottish Rite Hospital For Children | RAMANA, ANURADHA | 3775 | §112 | Final Rejection | 73d overdue | Pending | Sep 15, 2023 |
| 18044813 | METHOD FOR PREPARING INJECTABLE INJECTION COMPOSITION DERIVED FROM ANIMAL CARTILAGE, AND USE THEREOF | Kangstem Biotech Co., Ltd. | FIEBIG, RUSSELL G | 1655 | Other | Final Rejection | — | Pending | Aug 30, 2023 |
| 18457037 | CARDIOPROTECTIVE LIPIDS AND METHODS OF USE | Signpath Pharma, Inc. | O DELL, DAVID K | 1621 | §102 | Non-Final OA | — | Pending | Aug 28, 2023 |
| 18263914 | Macrohaplotypes for Forensic DNA Mixture Deconvolution | University Of North Texas Health Science Center AT Fort Worth | WILDER, CYNTHIA B | 1681 | DPOther | Non-Final OA | 75d | Pending | Aug 02, 2023 |
| 18348811 | Ophthalmic Implant | Evonik Corporation | SCHLIENTZ, LEAH H | 1618 | §103 | Final Rejection | — | Pending | Jul 07, 2023 |
| 18260012 | LIPIDS THAT REDUCE LUNG DAMAGE, IMPROVE PULMONARY FUNCTION AND DECREASE PRO-INFLAMMATORY CYTOKINES | Signpath Pharma, Inc. | RODRIGUEZ, RAYNA B | 1628 | §103 | Non-Final OA | — | Pending | Jun 29, 2023 |
| 18342881 | NONINVASIVE WATER CONTENT SENSOR | Southern Methodist University | FERDOUS, ZANNATUL | 2858 | §103 | Non-Final OA | 12d | Pending | Jun 28, 2023 |
| 18333812 | METHOD FOR PREPARING INJECTABLE INJECTION COMPOSITION DERIVED FROM ANIMAL CARTILAGE, AND USE THEREOF | Atems Co., Ltd. | FIEBIG, RUSSELL G | 1655 | §103 | Final Rejection | — | Pending | Jun 13, 2023 |
| 18256449 | BCAA-Lowering Compounds for Prevention and/or Treatment of Alzheimer's Disease and Related Disorders | Texas Tech University System | LADD, CAROLYN LOUISE | 1622 | §112 | Final Rejection | 13d | Pending | Jun 08, 2023 |
| 18307343 | TILTED PROPELLERS FOR ENHANCED DISTRIBUTED PROPULSION CONTROL AUTHORITY | Textron Innovations Inc. | GREEN, RICHARD R | 3647 | §112 | Non-Final OA | 9d overdue | Pending | Apr 26, 2023 |
| 18249988 | CARRIER PEPTIDE FRAGMENT AND USE THEREOF | Toagosei Co., Ltd. | NOAKES, SUZANNE MARIE | 1656 | §102 | Final Rejection | — | Pending | Apr 21, 2023 |
| 18016538 | Methods and Compositions for Diagnosing and Treating Cancer | La Jolla Institute For Immunology | KIRWIN, STEFANIE JOHANNA | 1677 | §103 | Non-Final OA | 65d | Pending | Jan 17, 2023 |
| 18004479 | Biomarkers for Identifying Relapses in Multiple Sclerosis | The Board Of Regents Of The University Of Oklahoma | FONTAINHAS, AURORA M | 1675 | §103 | Non-Final OA | 17d overdue | Pending | Jan 06, 2023 |
| 17925662 | Agent for Increasing Content of IgA Antibody in Milk | The University of Tokyo | KOROTCHKINA, LIOUBOV G | 1653 | §103 | Non-Final OA | 52d overdue | Pending | Nov 16, 2022 |
| 17921238 | Method for Exchanging and Storing Electronic Keys | Ilumi Solutions, Inc. | LYNCH, SHARON S | 2400 | §103 | Non-Final OA | 46d overdue | Pending | Oct 25, 2022 |
| 17971072 | MICROBIOME TRANSPLANTATION FOR OSTEOARTHRITIS THERAPY | The Board Of Regents Of The University Of Oklahoma | CRUM, MARY ABOU NADER | 1657 | §103 | Final Rejection | 34d | Pending | Oct 21, 2022 |
| 17956270 | MICRONUTRIENT DELIVERY TO GINGIVAL CREVICE | 3I Biotechnologies LLC | FUBARA, BLESSING M | 1613 | DPOther | Non-Final OA | — | Pending | Sep 29, 2022 |
| 17956249 | DISULFIRAM AND OTHER REDOX-RELATED COMPOSITIONS FOR BRAIN TUMORS | Texas Tech University System | BORI, IBRAHIM D | 1629 | §102 | Non-Final OA | 86d | Pending | Sep 29, 2022 |
| 17909480 | TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION | Texas Tech University System | FUBARA, BLESSING M | 1613 | DPOther | Non-Final OA | 68d | Pending | Sep 06, 2022 |
| 17908999 | MODIFIED TETRACYCLINES FOR TREATMENT OF ALCOHOL USE DISORDER, PAIN AND OTHER DISORDERS INVOLVING POTENTIAL INFLAMMATORY PROCESSES | Texas Tech University System | HOWELL, THEODORE R | 1628 | DPOther | Final Rejection | 71d | Pending | Sep 02, 2022 |
| 17782768 | METHOD AND COMPOSITIONS FOR ENGINEERING GRAPEVINE RED BLOTCH VIRUS-RESISTANT GRAPEVINE | Texas Tech University System | RADOSAVLJEVIC, ALEKSANDAR | 1662 | §103 | Non-Final OA | 13d | Pending | Jun 06, 2022 |
| 17779392 | Methods and Compositions for Modulationg Heterochromatin Dysfunction, Genomic Instability, and Associate Conditions | La Jolla Institute For Immunology | XIAO, YAN | 1642 | §112 | Non-Final OA | — | Pending | May 24, 2022 |
| 17749549 | METHODS AND COMPOSITIONS FOR CORRECTION OF AUTONOMIC DYSFUNCTIONS | Genetic Disease Investigators, LLC | SCHMITT, MICHAEL J | 1629 | Other | Non-Final OA | 33d | Pending | May 20, 2022 |
| 17747358 | MULTIGENIC MVA-SARS-COV-2 VACCINE | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | LI, BAO Q | 1671 | §112 | Non-Final OA | 18d overdue | Pending | May 18, 2022 |
| 17777183 | Method for Collecting Data for Predicting Occurrence of Anaphylaxis | Applied Medical Enzyme Research Institute Corporation | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §103 | Final Rejection | — | Pending | May 16, 2022 |
| 17768537 | Bi-Peptide with Affinity to Extracellular Matrix Proteins or Cells and to Growth Factors for Tissue Healing and Regeneration | Mayo Foundation for Medical Education and Research | STEELE, AMBER D | 1658 | §103 | Final Rejection | 280d overdue | Pending | Apr 13, 2022 |
| 17701051 | TREATMENT OF FERROPTOSIS | Nacuity Pharmaceuticals, Inc. | CHONG, YONG SOO | 1623 | §103 | Non-Final OA | 60d | Pending | Mar 22, 2022 |
| 17700591 | ANTIMICROBIAL PEPTIDES | Genvor Inc. | SHARMA, SANTOSH | 1663 | §103 | Non-Final OA | 65d | Pending | Mar 22, 2022 |
| 17591280 | CHITIN ANALOGS FOR THE TREATMENT OF KIDNEY DISEASES | AyuVis Research, Inc. | CRAIGO, BAHAR ALAWI | 1699 | §103 | Non-Final OA | 11d overdue | Pending | Feb 02, 2022 |
| 17585286 | Inhibitors of Multidrug Resistance Transporter P-Glycoprotein | Southern Methodist University | BAUER, NICOLA MARIA | 1621 | §102 | Non-Final OA | 29d | Pending | Jan 26, 2022 |
| 17625226 | Intratumoral TFR Cells Curtail Anti-PD-1 Treatment Efficacy | UNIVERSITY OF SOUTHAMPTON | DENT, ALANA HARRIS | 1643 | DP | Non-Final OA | 84d | Pending | Jan 06, 2022 |
| 17567400 | Wireless Communication Methods | Ilumi Solutions, Inc. | RENNER, BRANDON M | 2411 | §103 | Final Rejection | 87d overdue | Pending | Jan 03, 2022 |
| 17441990 | DIGITAL SUPPLY CHAIN MANAGEMENT SYSTEM | Mayo Foundation for Medical Education and Research | YU, ARIEL J | 3627 | §103 | Final Rejection | 45d overdue | Pending | Sep 22, 2021 |
| 17461812 | System, Method and Apparatus for Increasing Website Relevance While Protecting Privacy | Your Command, LLC | POPHAM, JEFFREY D | 2432 | §103 | Non-Final OA | 23d | Pending | Aug 30, 2021 |
| 17361763 | Personalized Medicine Approach for Treating Cognitive Loss | University Of North Texas Health Science Center AT Fort Worth | AKOGYERAM II, NICHOLAS A | 3686 | §101 | Non-Final OA | 27d | Pending | Jun 29, 2021 |
| 17339652 | TREATMENT OF CYSTINOSIS | Nacuity Pharmaceuticals, Inc. | KWON, JOHN SEUNGJAI | 1615 | §103 | Final Rejection | — | Pending | Jun 04, 2021 |
| 17284525 | Method to Express, Purify, and Biotinylate Eukaryotic Cell-Derived Major Histocompatibility Complexes | Texas Tech University System | YAO, LEI | 1642 | §103 | Final Rejection | 35d overdue | Pending | Apr 12, 2021 |
| 17275398 | Industrial Scale Processes Form a Covalent Bonded Monomer and Graphene Oxide Structures | Garmor Inc. | FOSS, DAVID ROGER | 1764 | §102 | Non-Final OA | — | Pending | Mar 11, 2021 |
| 17251359 | PREDICTIVE 7-GENE ASSAY AND PROGNOSTIC PROTEIN BIOMARKER FOR NON-SMALL CELL LUNG CANCER | West Virginia University | HANEY, AMANDA MARIE | 1682 | §112 | Non-Final OA | — | Pending | Dec 11, 2020 |
| 16915002 | HYBRID PROPULSION SYSTEM FOR CONVERTIBLE AIRCRAFT | BELL TEXTRON INC. | DANGOL, ASHESH | 3642 | §103 | Non-Final OA | 78d overdue | Pending | Jun 29, 2020 |
| 16853599 | Electronic Control Device | Ilumi Solutions, Inc. | RENNER, BRANDON M | 2411 | §103 | Non-Final OA | — | Pending | Apr 20, 2020 |
| 16433555 | Liposomal Mitigation of Drug-Induced Long QT Syndrome and Potassium Delayed-Rectifier Current | Signpath Pharma, Inc. | RONEY, CELESTE A | 1612 | §112 | Non-Final OA | — | Pending | Jun 06, 2019 |
| 16312346 | Blood Test for Screening Out Amyloid and Alzheimers Disease Presence | University Of North Texas Health Science Center AT Fort Worth | CHERNYSHEV, OLGA N | 1675 | §101 | Non-Final OA | 70d | Pending | Dec 21, 2018 |
| 16310981 | Method and Composition for Reducing Pathogens in Rendered Food Products Using Lactic Acid Bacteria | Texas Tech University System | GOUGH, TIFFANY MAUREEN | 1651 | §103 | Final Rejection | 74d overdue | Pending | Dec 18, 2018 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial